EMA to conduct major review into testosterone drugs
April 14, 2014Research and Development, Sales and Marketing EMA, EU, Europe, heart, testosterone
The European Medicines Agency has started a review of testosterone-containing medicines as concerns grow that they may increase the risk …
Roche/Novartis offices raided over anti-competitive activities
April 11, 2014Sales and Marketing Lucentis, Novartis, Roche, SHIP Cluster, avastin, wet AMD
French competition authorities are investigating Roche and Novartis in connection with their marketing of Lucentis for wet age-related macular degeneration …
Pfizer’s Jonathan Emms becomes new ABPI president
April 11, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Deepak Khanna, Pfizer, jonathan emms
Jonathan Emms, UK managing director of Pfizer, has taken up his appointment as president of the ABPI, after his election …
NICE to look again at Tamiflu after data saga
April 11, 2014Medical Communications, Sales and Marketing Jeremy Hunt, Roche, Tamiflu
The UK government has asked NICE to review its guidance for Roche’s troubled pandemic flu medicine Tamiflu after a new …
Merck gets hep C boost as competition ramps up
April 11, 2014Research and Development, Sales and Marketing Merck, daclatasvir, hep C, sovaldi
Merck has released promising data from a trial which uses two of its investigational compounds to treat patients with hepatitis …
Herceptin faces UK competition within months
April 11, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biocon, Herceptin, Hospira, Perjeta, breast cancer
Roche’s blockbuster breast cancer drug Herceptin may soon be under threat from copycat treatments after a court in the UK …
Regulatory woes eclipse Sun Pharma deal
April 10, 2014Manufacturing and Production, Sales and Marketing FDA, India, Ranbaxy, Sun Pharma
The $4 billion merger between Indian generic firms Sun Pharma and Ranbaxy has been soured by reports that the deal …
Tamiflu stockpiling ‘unjustifiable’ and wasted £424m
April 10, 2014Medical Communications, Research and Development, Sales and Marketing BMJ, Cochrane, Tamiflu, alltrials
Governments around the world may have squandered hundreds of millions of pounds on stockpiling Tamiflu, according to a review by …
DIA appoints Dr Haijun Dong as MD for DIA China
April 10, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing dia
Biopharmaceutical executive Dr Haijun (Lou) Dong has been named as the new managing director for DIA China. “Dr Dong brings …
Boehringer: ‘devil in detail’ on new drug pricing policy
April 10, 2014Medical Communications, Sales and Marketing Boehringer, PPRS, VBP, Zinta Krumins, alltrials, vba
Zinta Krumins, the newly-appointed managing director of Boehringer Ingelheim UK and Ireland, has warned that the ‘devil is in the …
NHS needs to understand drug costs better, says ABPI
April 10, 2014Medical Communications, Research and Development, Sales and Marketing ABPI, AGNSS, Deepak Khanna, NICE, Stephen Whitehead, Tarceva, soliris
The UK healthcare system is at risk of failing to adopt new, personalised medicines and must be willing to pay …
Hugo Mendoza takes on new role at Masters Speciality Pharma
April 9, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing t Masters Speciality Pharma
Masters Speciality Pharma has appointed Hugo Mendoza as its new business development director for the Caribbean and Central America territories. …
Former health minister tells NHS to embrace technology
April 9, 2014Medical Communications, Sales and Marketing Jeremy Hunt, autism, brain in hand, google, paperless, telehealth
The Labour MP and former health minister Ben Bradshaw has urged the National Health Service to do more when it …
Pharma needs ‘radical change’ says report
April 9, 2014Medical Communications, Sales and Marketing Chris Stirling, GSK, KPMG, digital
The pharma industry needs a complete overhaul of its entire business model with a greater focus on the patient, according …
Google Glass has ‘endless potential’ for Parkinson’s
April 9, 2014Medical Communications, Research and Development, Sales and Marketing Google glass, Parkinson's, Samsung, google
A new experiment by a British University is putting Google Glass to the test with Parkinson’s patients to see if …
EMA transparency agenda sees more delay
April 9, 2014Medical Communications, Sales and Marketing AbbVie, EFPIA, EMA, Europe, InterMune, alltrials, parliament, transparency
The European Medicines Agency is to further delay its policy over clinical trial transparency, saying it needs more time to …
Spectrum appoints Dr Dalna Harvey as regulatory project manager
April 8, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Spectrum, Wyeth, woodley
Spectrum Regulatory Solutions, a company that provides a consultancy to the healthcare industry, has added to its regulatory team by …
Dr Eliot Forster to lead MedCity
April 8, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boris Johnson, medcity
Dr Eliot Forster has been appointed chairman of MedCity Limited by the London mayor Boris Johnson. Dr Forster has 20 …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
